Screener
BioMarin Pharmaceuticals BMRN Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from BioMarin Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed October 28, 2025. Open the filing →
- Filed
- Oct 28, 2025, 2:07 PM EDT
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001048477-25-000107
FAQ
- What is BioMarin Pharmaceuticals's net margin?
- BioMarin Pharmaceuticals (BMRN) reported net margin of 16.8% in Q3 2025.
- How has BioMarin Pharmaceuticals's net margin changed year-over-year?
- BioMarin Pharmaceuticals's net margin increased by 43.7% year-over-year, from 11.7% to 16.8%.
- What is the long-term trend for BioMarin Pharmaceuticals's net margin?
- Over 4 years (2020 to 2024), BioMarin Pharmaceuticals's net margin has grown at a -24.4% compound annual growth rate (CAGR), from 45.9% to 15%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about BioMarin Pharmaceuticals's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude